Surgery Partners Announces Director Changes and Compensation Updates
Ticker: SGRY · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1638833
| Field | Detail |
|---|---|
| Company | Surgery Partners, Inc. (SGRY) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
Related Tickers: SGRY
TL;DR
Surg Partners (SGRY) board shakeup and exec comp changes filed. Watch for new director impact.
AI Summary
Surgery Partners, Inc. announced on January 10, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of a director and the election of a new director, along with updates to compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance and executive compensation matters, with no immediate financial distress or significant operational changes indicated.
Key Numbers
- 001-37576 — SEC File Number (Identifies the company's filing history with the SEC.)
- 47-3620923 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Surgery Partners, Inc. (company) — Registrant
- January 10, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Brentwood, Tennessee (location) — Principal Executive Offices
FAQ
Who is the departing director and who is the newly elected director?
The filing does not specify the names of the departing or newly elected directors, only that these events occurred.
What specific changes were made to the compensatory arrangements of certain officers?
The filing indicates updates to compensatory arrangements but does not detail the specific changes or the officers involved in this section.
What is the primary reason for these board and compensation changes?
The filing does not explicitly state the reason for the departure of the director or the election of a new one, nor the specifics of the compensation adjustments.
When were these changes effective?
The earliest event reported is dated January 10, 2025.
Does this filing indicate any financial performance issues?
No, this filing is related to corporate governance and executive compensation, not financial performance.
Filing Stats: 566 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2025-01-13 17:04:17
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share SGRY The Nasdaq Global Select
Filing Documents
- sgry-20250110.htm (8-K) — 23KB
- exhibit991pressreleasenewd.htm (EX-99.1) — 9KB
- sgrylogoa32.jpg (GRAPHIC) — 123KB
- 0001638833-25-000002.txt ( ) — 324KB
- sgry-20250110.xsd (EX-101.SCH) — 2KB
- sgry-20250110_lab.xml (EX-101.LAB) — 21KB
- sgry-20250110_pre.xml (EX-101.PRE) — 12KB
- sgry-20250110_htm.xml (XML) — 3KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits: 99.1 Press Release dated January 13, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SURGERY PARTNERS, INC. By: /s/ David T. Doherty David T. Doherty Executive Vice President, Chief Financial Officer Date: January 13, 2025